The palliative effects of octreotide in cancer patients
Identifieur interne : 00BB44 ( Main/Exploration ); précédent : 00BB43; suivant : 00BB45The palliative effects of octreotide in cancer patients
Auteurs : Andrew Dean [Australie]Source :
- Chemotherapy : (Basel) [ 0009-3157 ] ; 2001.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
Octreotide is an extremely useful compound for palliative care physicians. It appears to be active in a number of different pain states and may be given by the spinal and intraventricular route. Its actions in reducing gut motility and secretions make it a valuable adjunct in the management of inoperable bowel obstruction. The same actions make it a potent antidiarrheal agent. Octreotide will often succeed where other antidiarrheal agents fail. Its ability to reduce gut secretions has led to its use in the treatment of fistulae. It has also been proposed as a useful drug in the management of cachexia and ascites. Most of the existing evidence is based on small numbers of case reports and further larger trials are necessary.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 005C11
- to stream PascalFrancis, to step Curation: 000546
- to stream PascalFrancis, to step Checkpoint: 005651
- to stream Main, to step Merge: 00C996
- to stream Main, to step Curation: 00BB44
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">The palliative effects of octreotide in cancer patients</title><author><name sortKey="Dean, Andrew" sort="Dean, Andrew" uniqKey="Dean A" first="Andrew" last="Dean">Andrew Dean</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Palliative Care Service, Sir Charles Gairdner Hospital</s1><s2>Nedlands</s2><s3>AUS</s3><sZ>1 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Nedlands</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">01-0243004</idno><date when="2001">2001</date><idno type="stanalyst">PASCAL 01-0243004 INIST</idno><idno type="RBID">Pascal:01-0243004</idno><idno type="wicri:Area/PascalFrancis/Corpus">005C11</idno><idno type="wicri:Area/PascalFrancis/Curation">000546</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">005651</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005651</idno><idno type="wicri:doubleKey">0009-3157:2001:Dean A:the:palliative:effects</idno><idno type="wicri:Area/Main/Merge">00C996</idno><idno type="wicri:Area/Main/Curation">00BB44</idno><idno type="wicri:Area/Main/Exploration">00BB44</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">The palliative effects of octreotide in cancer patients</title><author><name sortKey="Dean, Andrew" sort="Dean, Andrew" uniqKey="Dean A" first="Andrew" last="Dean">Andrew Dean</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Palliative Care Service, Sir Charles Gairdner Hospital</s1><s2>Nedlands</s2><s3>AUS</s3><sZ>1 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Nedlands</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Chemotherapy : (Basel)</title><title level="j" type="abbreviated">Chemotherapy : (Basel)</title><idno type="ISSN">0009-3157</idno><imprint><date when="2001">2001</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Chemotherapy : (Basel)</title><title level="j" type="abbreviated">Chemotherapy : (Basel)</title><idno type="ISSN">0009-3157</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Analgesia</term><term>Analog</term><term>Antineoplastic agent</term><term>Chemotherapy</term><term>Diarrhea</term><term>Fistula</term><term>Gut</term><term>Human</term><term>Malignant tumor</term><term>Neuropeptide</term><term>Occlusion</term><term>Octreotide</term><term>Pain</term><term>Palliative treatment</term><term>Somatostatin</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Octréotide</term><term>Somatostatine</term><term>Analogue</term><term>Homme</term><term>Tumeur maligne</term><term>Traitement</term><term>Anticancéreux</term><term>Chimiothérapie</term><term>Traitement palliatif</term><term>Douleur</term><term>Analgésie</term><term>Occlusion</term><term>Intestin</term><term>Diarrhée</term><term>Fistule</term><term>Neuropeptide</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Octreotide is an extremely useful compound for palliative care physicians. It appears to be active in a number of different pain states and may be given by the spinal and intraventricular route. Its actions in reducing gut motility and secretions make it a valuable adjunct in the management of inoperable bowel obstruction. The same actions make it a potent antidiarrheal agent. Octreotide will often succeed where other antidiarrheal agents fail. Its ability to reduce gut secretions has led to its use in the treatment of fistulae. It has also been proposed as a useful drug in the management of cachexia and ascites. Most of the existing evidence is based on small numbers of case reports and further larger trials are necessary.</div></front></TEI><affiliations><list><country><li>Australie</li></country></list><tree><country name="Australie"><noRegion><name sortKey="Dean, Andrew" sort="Dean, Andrew" uniqKey="Dean A" first="Andrew" last="Dean">Andrew Dean</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00BB44 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00BB44 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:01-0243004
|texte= The palliative effects of octreotide in cancer patients
}}
| This area was generated with Dilib version V0.6.33. |  |